Disposition of 6000 shares by Hamilton James C of Arrowhead Pharmaceuticals at 28.03 subject to Rule 16b-3

ARWR Stock  USD 24.44  0.31  1.28%   
Slightly above 59% of Arrowhead Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Arrowhead Pharmaceuticals suggests that many traders are alarmed. Arrowhead Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Arrowhead Pharmaceuticals. The current market sentiment, together with Arrowhead Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Arrowhead Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Arrowhead Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Arrowhead daily returns and investor perception about the current price of Arrowhead Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Arrowhead Pharmaceuticals Officer: Chief Discovery/trans Medicine. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at news.google.com
Google News at Macroaxis
  
Disposition of 6000 common stock at 28.03 of Arrowhead Pharmaceuticals by Hamilton James C on 1st of April 2024. This event was filed by Arrowhead Pharmaceuticals with SEC on 2024-04-01. Statement of changes in beneficial ownership - SEC Form 4

Arrowhead Pharmaceuticals Current Investor Sentiment

Panic Vs Confidence

41

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Arrowhead Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Arrowhead Pharmaceuticals.

Arrowhead Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Arrowhead Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Arrowhead Pharmaceuticals Historical Investor Sentiment

Investor biases related to Arrowhead Pharmaceuticals' public news can be used to forecast risks associated with an investment in Arrowhead. The trend in average sentiment can be used to explain how an investor holding Arrowhead can time the market purely based on public headlines and social activities around Arrowhead Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arrowhead Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arrowhead Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Arrowhead Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Arrowhead Pharmaceuticals.

Arrowhead Pharmaceuticals Fundamental Analysis

We analyze Arrowhead Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arrowhead Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arrowhead Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earning

Price To Earning Comparative Analysis

Arrowhead Pharmaceuticals is currently under evaluation in price to earning category among related companies. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Arrowhead Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arrowhead Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Arrowhead Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arrowhead Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Arrowhead Pharmaceuticals Related Equities

WVEWave Life   4.25   
0%
100.0%
TERNTerns Pharmaceuticals   2.84   
0%
66.0%
ASMBAssembly Biosciences   2.65   
0%
62.0%
AMLXAmylyx Pharmaceuticals   1.50   
0%
35.0%
INCYIncyte   1.26   
0%
29.0%
IONSIonis Pharmaceuticals   0.19   
0%
4.0%
BPMCBlueprint Medicines   0.18   
0%
4.0%
APLSApellis Pharmaceuticals   0.06   
1.0%
0%
PRQRProQR Therapeutics   0.50   
11.0%
0%
CTMXCytomX Therapeutics   1.56   
36.0%
0%
BMRNBiomarin Pharmaceutical   1.62   
38.0%
0%
ANNXAnnexonInc   1.89   
44.0%
0%
DAWNDay One   2.28   
53.0%
0%
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:
Check out Arrowhead Pharmaceuticals Hype Analysis, Arrowhead Pharmaceuticals Correlation and Arrowhead Pharmaceuticals Performance.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.098
Earnings Share
(2.77)
Revenue Per Share
1.697
Quarterly Revenue Growth
(0.94)
Return On Assets
(0.25)
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.